Sign in
4

Changes in Ownership

AbbVie Inc. Filed Acc 0001415889-25-004456

CHIEF EXECUTIVE OFFICER acquired 61,362 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Michael Robert A. CHIEF EXECUTIVE OFFICER 2025-02-13 Grant or award +24,732 123,377 D
Michael Robert A. CHIEF EXECUTIVE OFFICER 2025-02-13 Grant or award +10,146 133,523 D
Michael Robert A. CHIEF EXECUTIVE OFFICER 2025-02-13 Grant or award +12,030 145,553 D
Michael Robert A. CHIEF EXECUTIVE OFFICER 2025-02-13 Grant or award +14,454 160,007 D
Derivatives
Michael Robert A. CHIEF EXECUTIVE OFFICER 2025-02-13 Grant or award · Option (Right to Buy) +83,333 83,333 D
Loading xslF345X05/form4-02182025_050203.xml…